Cetera Investment Advisers
INSM icon

Cetera Investment Advisers’s Insmed INSM Stock Holding History

Cetera Investment Advisers’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.18M Buy
48,622
+14,266
+42% +$1.73M ﹤0.01% 1594
2026
Q1 		$5.62M Sell
34,356
-4,087
-11% -$628K 0.01% 1432
2025
Q4 		$6.69M Sell
38,443
-2,728
-7% -$498K 0.01% 1272
2025
Q3 		$5.93M Buy
41,171
+9,709
+31% +$1.19M 0.01% 1302
2025
Q2 		$3.17M Buy
31,462
+10,783
+52% +$824K 0.01% 1508
2025
Q1 		$1.58M Buy
20,679
+10,525
+104% +$805K ﹤0.01% 1928
2024
Q4 		$701K Buy
10,154
+1,321
+15% +$95.1K ﹤0.01% 2417
2024
Q3 		$645K Buy
8,833
+1,598
+22% +$118K ﹤0.01% 2447
2024
Q2 		$485K Buy
+7,235
New +$281K ﹤0.01% 2619

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Cetera Investment Advisers's INSM Position: Q2 2026 in Review

Cetera Investment Advisers increased its Insmed (INSM) stake by 42% in Q2 2026, buying an estimated $1.73M and bringing the position to 48,622 shares worth $5.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1594.

Cetera Investment Advisers first reported a position in INSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $6.69M in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Cetera Investment Advisers held 48,622 shares of Insmed worth $5.18M as of Q2 2026.
  • Cetera Investment Advisers bought 14,266 Insmed shares in Q2 2026, an estimated $1.73M.
  • Insmed made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1594 holding.
  • Cetera Investment Advisers first reported a position in Insmed in Q2 2024 and has held it in 9 quarters since.
  • Cetera Investment Advisers's Insmed position peaked at $6.69M in Q4 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.